Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01148784 · ClinicalTrials.gov registry record · NA
Comparison of Doubled Quadrupled Versus Quadrupled Allograft Tissue Constructs for Anterior Cruciate Ligament (ACL) Reconstruction
A NA study of Anterior Cruciate Ligament and Injury, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 1
- Study location
NCT01148784 is a NA study of Anterior Cruciate Ligament and Injury that has completed, run by Oregon Health and Science University. The registered enrollment target is 102 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01148784, a NA study of Anterior Cruciate Ligament and Injury, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two different soft tissue allografts, double bundle tibialis anterior allograft or quadruple bundle hamstring allograft, used in repairing a torn anterior cruciate ligament (ACL) of the knee.
Conditions Studied
Interventions
- PROCEDURE ACL reconstruction
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-04-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01148784
The ClinicalTrials.gov registry entry for NCT01148784 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anterior Cruciate Ligament appearing as the primary indexed condition, and to 1 intervention - of which ACL reconstruction is the first listed.
NCT01148784 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT01148784 about?
NCT01148784 is a clinical study titled "Comparison of Doubled Quadrupled Versus Quadrupled Allograft Tissue Constructs for Anterior Cruciate Ligament (ACL) Reconstruction". The purpose of this study is to compare two different soft tissue allografts, double bundle tibialis anterior allograft or quadruple bundle hamstring allograft, used in repairing a torn anterior cruciate ligament (ACL) of the knee.
What is the current status of trial NCT01148784?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2010-06. Estimated completion is 2014-04-05.
What conditions does trial NCT01148784 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament, Injury.
What interventions are being tested in trial NCT01148784?
The interventions under investigation include: ACL reconstruction (PROCEDURE).
Who is sponsoring clinical trial NCT01148784?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01148784 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.